Մուշեղ Քեֆոյան2 ● Անդրեա Ջիուստինա5 ●
25-OH D <20
նախա և հետդաշտանադադարայինտարիքի կանայք (p = 0,01), հղի և ոչ հղի կանայք (p = <0.0001) և այն կանայք, ովքեր արևայրուք են ընդունել անցած տարվա ընթացքում (p = 0.004):
25-OH D- ≤8% for 25-OH D2- DBS-
D- t , : Excel (Microsoft, Redmond, WA):
2019 DBS 40 1238 : 32 (2.5%) : 1206 : 10
25-OH D2- 5 : 25-OH D2 2.8 / `4.8 / : , 25-OH D- 25-OH D3 : 25-OH D- 20 ± 8 / (>54%) 25-OH D- <20 / , 13%- <12 / : 18-24 25-OH D 20 ± 8 / , 13% - `12 / - ; 25-64 21 ± 7 / `10% - ` 12 / - , > 65 18 / (SD 7.5) (21%) 12 / - 25-OH D (.. 1, 2): 25-OH D - ` (19 20 / , p = 0.00004): , D- , 25 OH D- (p values 0.004, 0.0002, and 0.03 respectively) (p = 0.01), (p = <0.0001) (p = 0.004): , 25- OH D- , , , , , , D- , , 3 25-OH D- :
2
D- [7, 34]: : , D- (<12//) , 13 % 20% 65 – , , : , , D- D- : (18–24 , 25–64 65 ), , , , , , D- : . , D- , , , , 20%- 15 , 53%- 35- [35]: , , , : , D-12 / - 10-15% ` , D- , D- - 1940- D- , , , D- D- : , D- [36]: , D- : , [37]: D- , ` , , ,
a Ոչ բոլոր մասնակիցներն են պատասխանել բոլոր հաչցերի, հետևաբար տոկոսային սանդղակը ներկայացված է ըստ պատասխանողների, ոչ ըստ բնակչության քանակի
bՀաշվարկված է ANOVA մեթոդով
cԴաշտանադադար մինչև 45 տ.
, DBS , , : , ID-LC-MS/MS 25- D- : ( 1300- ), ( 3 ) : , , , , , , :, :
, , / 1964 . – : - :
. , :
. Springer Nature-
Լիցենզիայի կրկնօրինակը տեսնելու համար, կարող եք անցնել հղումով.
http://creativecommons. org/licenses/by/4.0/.
Rizzoli R, Boonen S, Brandi M-L, Bruyère O, Cooper C, Kanis JA, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteo- porosis and Osteoarthritis (ESCEO). Curr Med Res Opin. 2013;29:305–13.
Giustina A, Adler RA, Binkley N, Bouillon R, Ebeling P, Lazaretti-Castro M, et al. Controversies in vitamin D: summary statement from an international conference. J Clin Endocrinol Metab. 2019;104:234–40.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–81.
Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59:881–6.
Hewison M. An update on vitamin D and human immunity. Clin Endocrinol. 2012;76:315–25.
Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y. Vitamin D and autoimmunity. Scand J Rheumatol. 2016;45:439–47.
Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18:153–65.
Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W. Vita- min D and cardiovascular disease prevention. Nat Rev Cardiol. 2016;13:404–17.
Kulling PM, Olson KC, Olson TL, Feith DJ, Loughran TP. Vitamin D in hematological disorders and malignancies. Eur J Haematol. 2017;98:187–97.
DeLuca HF. Vitamin D: historical overview. Vitam Horm. 2016;100:1–20.
Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96:365–408.
Bouillon R, Marcocci C, Carmeliet G, Bikle D, White J, Dawson- Hughes B, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40:1109–51.
Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med. 1998;338:736–46.
van Schoor N, Lips P. Global overview of vitamin D status. Endocrinol Metab Clin North Am. 2017;46:845–70.
Wacker M, Holick M. Sunlight and vitamin D: a global per- spective for health. Dermatoendocrinology. 2013;5:51–108.
Giustina A, Adler RA, Binkley N, Bollerslev J, Brouillon R, Dawson-Hughes B, et al. Consensus statement from 2nd inter- national conference on controversies in vitamin D. Rev Endocr Metab Disord. 2020;21:89–116.
Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon T, Brannon PM, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the first international conference on controversies in vitamin D. Br J Clin Pharmacol. 2018; 84:2194–207.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon C, Hanley D, Heaney R, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy Press; 2010.
Central Intelligence Agency, 2021. The World Factbook. ‘Arme- nia' https://www.cia.gov/the-world-factbook/countries/armenia. Accessed 06 May 2021.
Yerevan Municipality. ‘Climate conditions’. https://www.yerevan. am/en/climate-conditions.
Accessed 28 Aug 2020.
Lesnyak O, Sahakyan S, Zakroyeva A, Bilezikian JP, Hutchings N, Babalyan V, et al. Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate. Arch Osteoporos. 2017;12:98.
Lips P, Bilezikian JP, Bouillon R. Vitamin D: giveth to those who needeth. JBMR. 2019;4:e10232.
Ebeling PR, Adler RA, Jones G, Liberman UA, Mazziotti G, Minisola S, et al. Management of endocrine disease: therapeutics of Vitamin D. Eur J Endocrinol. 2018;179:R239–59.
Giustina A. Rapid response to: preventing a covid-19 pandemic: can high prevalence of severe hypovitaminosis D play a role in the high impact of Covid infection in Italy? BMJ. 2020;368:m810.
Balian R. ‘Vitamin D levels in women of Armenia.’ 9th Interna- tional Osteoporosis Symposium. Yerevan, Armenia; 2014.
Katz J. Sample-size implications for population-based cluster surveys of nutritional status. Am J Clin Nutr. 1995;61:155–60.
Branca F, Coclite D, Napoletano A, Rossi L. Report: the Health and Nutritional Status of Children and Women in Armenia. Rome, Italy: National Institute of Nutrition; 1998.
Goswami R, Kochupillai N, Gupta N, Goswami D, Singh N, Dudha A. Presence of 25(OH) D deficiency in a rural North Indian village despite abundant sunshine. J Assoc Physicians India. 2008;56:755–7.
Madar AA, Gundersen TE, Haug AM, Meyer HE. Vitamin D supplementation and vitamin D status in children of immigrant background in Norway. Public Health Nutr. 2017;20:2887–92.
Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J. 2003;20:453–8.
Eyles D, Anderson C, Ko P, Jones A, Thomas A, Burne T, et al. A Sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin Chim Acta. 2009;403:145–51.
Dirks NF, Esper HW, van Herwaarden AE, van den Ouweland JM, Kema IP, Krabbe JG, et al. Various calibration procedures result in optimal standardization of routinely used 25(OH)D ID- LC-MS/MS methods. Clin Chim Acta. 2016;462:49–54.
Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer-Pietsch B, Bianchi ML, et al. Current vitamin D status in European and Middle East Countries and strategies to prevent vitamin D deficiency: a position statement of the european calci- fied tissue society. Eur J Endocrinol. 2019;180:23–54.
National Statistical Service, Republic of Armenia. Census 2011— Initial results. Yerevan: NSS RA; 2012. [Original in Armenian].
Pilz S, März W, Cashman K, Kiely M, Whiting S, Holick M, et al. Rationale and plan for vitamin D food fortification: a review and guidance paper. Front Endocrinol. 2018;9:373.
Moulas AN, Vaiou M. Vitamin D fortification of foods and pro- spective health outcomes. J Biotechnol. 2018;285:91–101.
2021-09-25
